NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Management View CEO Dave Rosa highlighted the strong performance of the OneRF ablation system, which is the first FDA-cleared product ...

Zimmer Biomet posted fourth-quarter revenue growth of 5% in constant currency, which is generally consistent with the preceding quarters in 2024. Zimmer Biomet posted solid third-quarter results ...

Please go ahead. Thank you, Operator, and good morning, everyone. Welcome to Zimmer Biomet Biomet's fourth quarter 2024 earnings conference call. Joining me on today's call are Iwan Tornos ...

Zimmer Biomet provided 2025 guidance of constant currency ... supported by increased penetration of the Persona portfolio and ROSA Robotics. Hips grew 4%, bolstered by the initial rollout of ...

Zimmer Biomet's ZBH strategic efforts to bolster the Knee business are expected to drive growth in the upcoming quarters. The stabilization of the global musculoskeletal market looks promising for ...

(Reuters) -Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices. The deal will give Zimmer ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings ... in conjunction with Hip Insights and ROSA Hip Navigation, we now have the broadest navigation ...